Mainar, Peter John .
HRN: 26-42-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/27/2024
01/03/2025
IVT
300mg
Q6
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes